Porton Biopharma Limited
Porton Biopharma Limited has executed an exclusive licence agreement for worldwide marketing, sales and distribution of Erwinaze/Erwinase to Clinigen Group plc
Financial Advisor
$246.0 Million
Intricon Corp.
Intricon Corporation has been acquired by Altaris Capital Partners, LLC
Financial Advisor
$2.3 Billion
The Carlyle Group
Resonetics, LLC.
GTCR has sold a significant stake in Resonetics, LLC to The Carlyle Group
Financial Advisor
$1.2 Billion
Preventice Inc.
Preventice Solutions, Inc. has been acquired by Boston Scientific Corporation
Financial Advisor
$4.0 Billion
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. has been acquired by Bayer Pharmaceuticals
Financial Advisor
$340.0 Million
Veran Medical Technologies, Inc.
Veran Medical Technologies, Inc. has been acquired by Olympus Corporation
Financial Advisor
$850.0 Million
Key Surgical, Inc.
Key Surgical, a portfolio company of Water Street Healthcare Partners, has been acquired by STERIS
Financial Advisor
$400.0 Million
Sentry Data Systems, Inc.
Sentry Data Systems, Inc., a portfolio company of Abry Partners, has been acquired by Craneware plc
Financial Advisor
$406.0 Million
NXThera, Inc.
NxThera Inc. has been acquired by Boston Scientific
Financial Advisor
$2.0 Billion
Abaxis, Inc.
Abaxis, Inc. has been acquired by Zoetis Inc.
Financial Advisor
Subscribe to Financial Advisor

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.